Daily News Podcast

FDA approves sufentanil


 

The FDA approves sufentanil for managing pain in patients who are in certified medical health care settings. Also today, Crohn’s disease is tied to anal canal high-risk HPV vaccination. Also today, ultrasound denervation tops radiofrequecy ablation for resistant hypertension, and primary care needs pile up for patients with sickle cell disease.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Screening for intimate partner violence
MDedge Dermatology
Validation for SLE low-disease definition
MDedge Dermatology
Heather Yeo: Surgical Residency Attrition
MDedge Dermatology
AKI linked to later dementia
MDedge Dermatology
Part B scheme raises concerns
MDedge Dermatology
NSAID risk score validated for CV events
MDedge Dermatology
TENS improves fibromyalgia pain
MDedge Dermatology
Thiopurines linked to zoster in IBD patients
MDedge Dermatology
Is it time to revise ASCVD cardiovascular risk threshold?
MDedge Dermatology
Samuel Shem: House of God
MDedge Dermatology